Correlation Between BioLife Solutions and AngioDynamics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLife Solutions and AngioDynamics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Solutions and AngioDynamics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLife Solutions and AngioDynamics, you can compare the effects of market volatilities on BioLife Solutions and AngioDynamics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Solutions with a short position of AngioDynamics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Solutions and AngioDynamics.

Diversification Opportunities for BioLife Solutions and AngioDynamics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between BioLife and AngioDynamics is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Solutions and AngioDynamics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AngioDynamics and BioLife Solutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Solutions are associated (or correlated) with AngioDynamics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AngioDynamics has no effect on the direction of BioLife Solutions i.e., BioLife Solutions and AngioDynamics go up and down completely randomly.

Pair Corralation between BioLife Solutions and AngioDynamics

Given the investment horizon of 90 days BioLife Solutions is expected to under-perform the AngioDynamics. But the stock apears to be less risky and, when comparing its historical volatility, BioLife Solutions is 1.01 times less risky than AngioDynamics. The stock trades about -0.06 of its potential returns per unit of risk. The AngioDynamics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  935.00  in AngioDynamics on April 23, 2025 and sell it today you would lose (36.00) from holding AngioDynamics or give up 3.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioLife Solutions  vs.  AngioDynamics

 Performance 
       Timeline  
BioLife Solutions 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioLife Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
AngioDynamics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days AngioDynamics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, AngioDynamics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

BioLife Solutions and AngioDynamics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLife Solutions and AngioDynamics

The main advantage of trading using opposite BioLife Solutions and AngioDynamics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Solutions position performs unexpectedly, AngioDynamics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will offset losses from the drop in AngioDynamics' long position.
The idea behind BioLife Solutions and AngioDynamics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments